Bufexamac is a non-steroidal anti-inflammatory drug (NSAID) derivative of butoxyphenylacetohydroxamic acid, primarily utilized as a topical or rectal agent for managing various inflammatory skin conditions.… Read more














Bufexamac is a non-steroidal anti-inflammatory drug (NSAID) derivative of butoxyphenylacetohydroxamic acid, primarily utilized as a topical or rectal agent for managing various inflammatory skin conditions. Although its clinical use has been limited in some regions due to hypersensitivity reactions, it remains a subject of ongoing analytical study. This category contains a comprehensive selection of Bufexamac reference standards, including the active pharmaceutical ingredient, its identified pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and quality control assessments. By utilizing these precise standards, researchers can accurately quantify degradation products and trace residues, ensuring the safety and efficacy of similar anti-inflammatory formulations during development and regulatory compliance testing.